Atea Pharmaceuticals (AVIR) Stock Price, Chart & Analysis
Alpha Vantage · debelegger.nl · · AI-summarised by FinFlash
This article provides a detailed analysis of Atea Pharmaceuticals (AVIR) stock, including its latest price ($4.22), market capitalization ($336.86M), and key financial figures such as revenue growth (+295.2% last quarter). It also covers analyst expectations, a "Belegger score" of 32 out of 100, and various valuation metrics, concluding with hypothetical future price scenarios and upcoming quarterly figures.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.